Trial intelligence / Profile preview

Ketamine in Alcohol Use Disorder

NCT04084860Phase 2Unknown

Sponsor
New York State Psychiatric Institute
Start
Nov 2019
Primary completion
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ketamine in alcohol use disorder (AUD), sponsored by New York State Psychiatric Institute. Status: unknown.

02

Drugs

ketamine
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT04084860.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04084860.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call